レポートナンバー 0000040098
世界の性感染症(STD)市場(2024-2029):エイズ/HIV、軟性下疳、クラミジア、淋病、鼠径肉芽腫、ヘルペスI/II、リンパ肉芽腫、マイコプラズマ、パピローマウイルス、梅毒、トリコモナス膣検査:アメリカ・ヨーロッパ・日本 -サプライヤーシェアと検査別の売上セグメント予測、競合情報、新興技術、計測機器、および機会
VPGMarketResearch
2024-2029 Global Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
発刊日
2024/11/12
言語英語
体裁PDF
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
レポート概要
この新しいレポートでは、新興の検査、技術、機器、国別の売上予測、市場シェア、主要サプライヤーの戦略的プロファイルなど、世界の性感染症検査市場の分析を提供しています。
このレポートでは、以下に対するアメリカ、ヨーロッパ(フランス、ドイツ、イタリア、スペイン、イギリス)、日本の性感染症市場の詳細な分析を示しています
- 軟性下疳
- クラミジア
- 淋病
- ヘルペス(I/II、VI)
- パピローマウイルス(パップスメア、HPV)
- 梅毒
このレポートでは、国別および以下の市場セグメント別の検査量と売上予測を提供します。
- 病院
- 商業/民間研究所
- 医師の診療所
- 公衆衛生研究所
このレポートでは、検査量と売上予測に加えて、STD 診断製品の主要サプライヤーの売上と市場シェアの予測を検査別および国別に示しています。また、分子診断、モノクローナル抗体、免疫測定、IT、その他の新興技術の市場アプリケーションを調査し、STD 検査に使用される主要な分析装置の機能と動作特性をレビューし、革新的な技術と製品を開発している主要サプライヤーと潜在的な市場参入者のプロファイルを作成し、新たな機会、代替市場浸透戦略、市場参入障壁/リスク、および戦略計画の問題を分析します。
方法論
このレポートは、アメリカ、ヨーロッパ主要5カ国、および日本で革新的な製品を開発している大手診断会社や新興企業の研究所長、幹部へのインタビューを含む、一次情報源と二次情報源の組み合わせに基づいています。
一次情報源に加えて、最新の技術およびビジネス出版物、メーカーの製品および財務文献、およびVPGMarketResearchの独自のデータファイルの包括的なレビューが実施されました。
レポート詳細
目次
Table of Contents
I. Introduction
II. Worldwide Market and Technology Overview
A. Major STD Tests
1. AIDS/HIV
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Lymphogranuloma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review
C. Emerging Diagnostic Technologies
III. Country Test Volume and Sales Forecasts,
Supplier Shares
France: Sales Forecasts and Supplier Shares
Germany: Sales Forecasts and Supplier Shares
Italy: Sales Forecasts and Supplier Shares
Japan: Sales Forecasts and Supplier Shares
Spain: Sales Forecasts and Supplier Shares
UK: Sales Forecasts and Supplier Shares
USA: Sales Forecasts and Supplier Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Competitive Assessments
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman
Coulter/Cepheid/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
GSK Biologicals
Hologic
Illumina
LabCorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Lonza
Myriad Genetics
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
SeraCare
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako
List of Tables
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
France
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Diagnostics Sales by Major Supplier
France
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Herpes Testing Market Diagnostics Sales
by Major Supplier
France
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Germany
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Germany
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Herpes Testing Market Diagnostics Sales
by Major Supplier
Germany
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Italy
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Diagnostics Sales by Major Supplier
Japan
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Japan
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Herpes Testing Market Diagnostics Sales
by Major Supplier
Japan
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Spain
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Diagnostics Sales by Major Supplier
Spain
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Herpes Testing Market Diagnostics Sales
by Major Supplier
Spain
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.K.
Chancroid
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.K.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chancroid Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chlamydia Diagnostics Sales by Major Supplier
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier